While solid evidence has demonstrated the protective roles of inflammasomes and IL-18 in AOM/DSS-induced colon cancer, it would be informative to determine whether inflammasomes, IL-1β or IL-18 inhibit or promote colon cancer development in chronic or genetic colon cancer models as well as in human colorectal cancer patients. This evidence concerns the gene IL1B and malignant colon neoplasm.